Unhealthy
lifestyle patterns and food habits are averse to human health and causes
diseases like diabetes, cancer and many other diseases. On a global basis,
cancer has resulted to a large scale mortality which is continuously rising.
The dominance of a fatal disease and the necessity to prevent such death toll
is primarily driving this market. Rapid technological advancement and its
implementation in the healthcare sector is bolstering this market. Supportive
measures undertaken by various organizations and the governments to spread
awareness with regard to the industry are fueling this market. The development
of healthcare infrastructure and diagnostic centers are augmenting this market.
The premium price of diagnosis of cancer and the paucity of reimbursement
policies are hindering this market. However, the rising proportion of
population suffering from this chronic disease is expected to broaden the
consumer base for this market.
The
global Cancer Diagnostics market size is projected to reach US$ 209.7 billion
by 2028, from US$ 106.8 billion in 2020, at a CAGR of 8.8% during 2021-2028.
In
terms of production side, this report researches the Cancer Diagnostics
production capacity, value, ex-factory price, growth rate, market share by
manufacturers, regions (or countries) and by Type.
In
terms of consumption side, this report focuses on the consumption of Cancer
Diagnostics by regions (countries) and by Application.
The
global Cancer Diagnostics market is thoroughly, accurately, and comprehensively
assessed in the report with a large focus on market dynamics, market
competition, regional growth, segmental analysis, and key growth strategies.
Buyers of the report will have access to verified market figures, including
global market size in terms of revenue and volume. As part of production
analysis, the authors of the report have provided reliable estimations and
calculations for global revenue and volume by Type segment of the global Cancer
Diagnostics market. These figures have been provided in terms of both revenue
and volume for the period 2016-2028. Additionally, the report provides accurate
figures for production by region in terms of revenue as well as volume for the
same period. The report also includes production capacity statistics for the
same period.
Geographic Segmentation
The
report offers exhaustive assessment of different region-wise Cancer Diagnostics
markets such as North America, Europe, China and Japan, etc. Key regions
covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia,
China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand,
Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For
the period 2016-2028, the report provides country-wise revenue and volume sales
analysis and region-wise revenue and volume analysis of the global Cancer
Diagnostics market. For the period 2020-2028, it provides sales (consumption)
analysis and forecast of different regional markets by each application as well
as type segment in terms of volume.
Manufacturers
The
report includes comprehensive company profiling of leading and emerging
companies competing in the global Cancer Diagnostics market. It provides a
detailed list of players operating at a global level. The players have been
listed according to the type of products they offer in the global Cancer
Diagnostics market and other factors. As part of the company profiling, the
analysts authoring the report has provided the market entry year of each player
considered for the research study. The report also offers extensive price,
volume sales, and revenue analysis by the manufacturer at the global level for
the period 2016-2028.
By Type and Application
Segments
The
report includes a detailed analysis of leading and type and application
segments of the global Cancer Diagnostics market. All of the segments covered
in the report are broadly analyzed based on some deciding factors. The
segmental analysis section of the report offers revenue sales analysis and
forecast of the global Cancer Diagnostics market by each type segment for the
period 2016-2028. It also offers volume sales (consumption) analysis and
forecast of the global Cancer Diagnostics market by each type segment for the
same period. Also, it provides volume sales (consumption) analysis and forecast
of the global Cancer Diagnostics market by each application segment for the
same period.
This report includes the
following manufacturers:
GE
Healthcare
Abbott
Laboratories Inc
Siemens
Healthcare GmbH
Qiagen
N.V.
F. Hoffmann-La
Roche Ltd
Beckton
Dickinson & Company
Agilent
Technologies Inc
C.R.
Bard Inc
Illumina
Inc
Thermo
Fisher Scientific Inc
Market
Segment by Type
Laboratory
Tests
Genetic
Tests
Imaging
Endoscopy
Biopsy
Others
Market
Segment by Cancer Type
Breast
Cancer
Colorectal
Cancer
Cervical
Cancer
Lung
Cancer
Prostate
Cancer
Skin
Cancer
Blood
Cancer
Kidney
Cancer
Liver
Cancer
Pancreatic
Cancer
Ovarian
Cancer
Others
Market
Segment by End Use
Diagnostic
Centers
Hospitals
and Clinics
Research
Institutes
Others
Research Methodology
To compile
the detailed study of the global Cancer Diagnostics market, a robust research
methodology has been adopted that aids in determining the key insights and also
evaluates the growth prospects of the Cancer Diagnostics market. Data Insights
Partner Research analysts have conducted in-depth primary and secondary
research to obtain crucial insights into the Cancer Diagnostics market. To
carry out secondary research, the analysts have collected the information
through company annual reports, journals, company press releases, and paid
databases that were referred to gain and identify better opportunities in the
global market.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the Cancer
Diagnostics market, size of the
market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of
forecast: 2020-2028, taking into account 2019 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, competitive market strategies of leading market players,
emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world Cancer Diagnostics market is done by taking into account various parameters such
as company strategies, distribution strategies, product portfolio, financial
performance, key developments, geographical presence, and company overview
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of Type of models, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world market
for Cancer Diagnostics caters to the needs of various stakeholders pertaining to this
industry, namely suppliers, manufacturers, investors, and distributors for Cancer
Diagnostics market. The research
also caters to the rising needs of consulting and research firms, financial
analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the investment
opportunities in the Cancer Diagnostics market
v
Identification
of key factors driving investment opportunities in the Cancer
Diagnostics market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position yourself
to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants